Back to links
Back to links
Back to links
Back to links
Back to links
Back to links
event details

2018 CGA Annual Meeting

October 14-16, 2018
San Diego, CA

2018 Abstract Submissions

For more information on the abstract submission click here.

Hotel Information

Location:
Hilton San Diego Bayfront
1 Park Blvd
San Diego, CA 92101

A block of rooms has been reserved at the Hilton San Diego Bayfront for the 2018 CGA Annual Meeting attendees at a discounted rate of $235.00 plus tax. The discounted hotel rate is available through Friday, September 21. After September 21, rooms are subject to availability and prevailing rates.

To book your room, please visit the CGA Annual Meeting dedicated website by clicking here. You can als call the hotel directly at 1-800-HILTONS and reference the "CGA" when booking your room.

2018 Annual Meeting

The 2018 CGA Annual Meeting is being held October 14-16, at the Hilton San Diego Bayfront in San Diego, CA The meeting will be before The American Society of Human Genetics being held October 16-20, 2018 in San Diego, CA. The annual conference will provide critical data and information designed to keep clinicians and scientists up-to-date on new developments in hereditary gastrointestinal cancer research, including implications for physicians, nurses, and genetic counselors to make informed decisions about the prevention, diagnosis, and treatment of patients with hereditary gastrointestinal cancer syndromes. The CGA Annual Conference, in its 22nd year, is the premier conference directed to colorectal surgeons, medical oncologists, gastroenterologists, researchers, geneticists, nurses, colorectal cancer registry coordinators, genetic counselors, psychologists and other professionals involved in the care of individuals with hereditary gastrointestinal cancer, including colorectal, esophageal, pancreatic, gastric, and small bowel cancers.

Who Should Attend
The 2018 CGA Annual Meeting will be directed to colorectal surgeons, medical oncologists, gastroenterologists, researchers, geneticists, nurses, colorectal cancer registry coordinators, genetic counselors, psychologists and other professionals involved in the care of individuals with hereditary gastrointestinal cancer, including colorectal, esophageal, pancreatic, gastric, and small bowel cancers.

Objectives
After completing this activity, participants will be able to do the following:

  • Summarize recent research on the basic biology of gastrointestinal cancer development, including modifiers of the hereditary phenotypes
  • Describe potential implications for clinical practice
  • Implement new approaches to screening and preventing gastrointestinal cancers
  • Summarize the evidence for new diagnostics, devices, and pharmaceuticals
  • Describe the impact of newly discovered genes and the use of recently introduced gene panels to diagnose and manage hereditary gastrointestinal cancer syndromes
  • Institute use of clinical and genetic modifiers of the hereditary cancer risk in their clinical practice
  • Define the changing care models for diagnosis and management of various hereditary cancer syndromes
  • List the surgical approaches to hereditary gastrointestinal cancer syndromes for both treatment and prophylaxis
  • Describe patient criteria for referral for surgery that offers optimal outcomes

Credit Designation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the New Mexico Medical Society (NMMS) through the joint providership of Rehoboth McKinley Christian Health Care Services (RMCHCS) and The Collaborative Group of the Americas in Inherited Colorectal Cancer. RMCHCS is accredited by the NMMS to provide continuing medical education for physicians.

RMCHCS designates this live activity for a maximum of TBD AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.